| Name | Apria Healthcare Llc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 1395 Greg St, Ste 113, Sparks, Nevada 89431 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (775) 352-7742 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
Seemingly healthy cells may in fact hide clues that lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Institute.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.
› Verified 6 days ago
| NPI Number | 1316057854 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1395 Greg St, Suite 113, Sparks, NV 89431 |
| Phone Number | 775-352-7742 |
News Archive
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
Seemingly healthy cells may in fact hide clues that lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Institute.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.
› Verified 6 days ago
News Archive
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
Seemingly healthy cells may in fact hide clues that lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Institute.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.
› Verified 6 days ago
20/20 Vision Llc Type: Medicare Supplier Location: 738 Prater Way, Sparks, Nevada 89431 Phone: (715) 356-3937 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1395 Greg St, Sparks, Nevada 89431 Phone: (775) 352-7742 | |
Cpap & More Type: Durable Medical Equipment & Medical Supplies Supplier Location: 410 N Maccarran Blvd, Sparks, Nevada 89431 Phone: (775) 331-5700 | |
Demers Family Vision Group Inc Type: Medicare Supplier Location: 670 N Mccarran Blvd, Sparks, Nevada 89431 Phone: (775) 358-1317 | |
Oxytech Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 1544 Pittman Ave, Sparks, Nevada 89431 Phone: (775) 284-8890 |